D
engue is a globally important mosquito-borne viral infection, with about 4 billion people at risk and 100 million symptomatic cases annually. 1 In 1997, the World Health Organization (WHO) classified symptomatic dengue as dengue fever and dengue hemorrhagic fever, with the latter having 4 grades of severity, where grades III and IV were considered to represent dengue shock syndrome. 2 Dengue hemorrhagic fever is a more severe form of dengue fever, with evident plasma leakage leading to spontaneous bleeding, organ failure or hypovolemic shock. In 2009, the WHO published a new classification for dengue, adding central nervous system (CNS) involvement as a criterion for severe dengue. 3 Complications of CNS involvement in severe dengue include dengue encephalopathy or encephalitis, post-dengue immune-mediated syndromes and cerebrovascular complications. 4 The mediators released during dengue infection, such as cytokines, chemokines and complement, have vasoactive or procoagulant effects leading to thrombocytopenia, disseminated intravascular coagulation and vasculitis, which may result in stroke. 4 It is challenging to treat stroke in patients with dengue because of the difficulty of administering thrombolytic agents to patients with a bleeding tendency. Knowing the incidence of and risk factors for stroke in patients with dengue would be helpful. However, only a few cases of denguerelated hemorrhagic or ischemic stroke have been reported. [5] [6] [7] [8] [9] The risk of stroke in patients with dengue remains unclear.
In Taiwan, patients with dengue are under surveillance by the Centers for Disease Control, R.O.C. (Taiwan) (known as the Taiwan CDC), through a routine laboratory-based screening and diagnosis system. 10 All hospital-diagnosed cases of dengue must be reported to the Taiwan CDC for confirmation and subsequent surveillance. We conducted a population-based cohort study using data from the Taiwan National Health Insurance Research Database (NHIRD), to investigate the risk of stroke in patients with dengue, and compared this risk with the risk in a matched population of patients without dengue. We also performed subgroup analyses to examine the risk differences.
Methods

Data source
For this retrospective cohort study, we retrieved data concerning patients with dengue from the NHIRD, which enrolled about 26 million residents in Taiwan between 1996 and 2013, covering more than 99% of the population of Taiwan. The database contained detailed health care information for each enrollee, with encryption to protect personal privacy. Disease identification in the NHIRD follows the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM). Previous studies have validated the accuracy of disease diagnosis in the NHIRD,
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INTERPRETATION:
Dengue fever was associated with an increased risk of stroke in the first few months after diagnosis. The effect of dengue on stroke may be acute rather than chronic.
including diagnosis of ischemic stroke, showing high sensitivity (94.5%-97.3%) and high positive predictive value (88.4%-97.8%). 11, 12 The Bureau of National Health Insurance in Taiwan routinely reviews medical charts and claims to ensure the validity and accuracy of data coding in the NHIRD.
Study population and outcome
The study population comprised 2 cohorts: the dengue and control cohorts. The dengue cohort consisted of all cases of dengue newly diagnosed in hospital between 2000 and 2012, specifically dengue fever (ICD-9-CM code 061) and dengue hemorrhagic fever (ICD-9-CM code 065.4). To avoid surveillance bias related to hospital admission, the control cohort consisted of hospital inpatients without a diagnosis of dengue. For each patient, the index date was defined as the date of first diagnosis of dengue fever or dengue hemorrhagic fever (dengue cohort) or the admission date (control cohort). We defined patients with separate diagnosis dates during the follow-up period as having repeat dengue infections.
The main study outcome was stroke (ICD-9-CM codes 430-437), as documented in hospital records. We also assessed hemorrhagic stroke (ICD-9-CM codes 430-432) and ischemic stroke (ICD-9-CM codes 433-434) in our stratified analysis. We excluded patients with stroke or late effects of stroke (ICD-9-CM codes 430-438) occurring before the index date and those with missing information during follow-up. To control confounding related to other recent infections, 13, 14 we also excluded patients with any bacterial, viral or other infection within 2 months before the index date.
We followed all participants from the index date to the first of date of outcome, date of death or end of 2013. We used a propensity-score matching method to match each patient with dengue with 1 control patient on the following characteristics: sex, age, year of index date and covariables listed in Table 1 .
The diagnosis of dengue was confirmed by laboratory testing, according to any of the criteria of the Taiwan CDC: positive result on testing for dengue virus genome by real-time polymerase chain reaction; detection of dengue virus nonstructural protein 1 (NS1); positive seroconversion or a fourfold or greater increase in dengue-specific immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies from acute and convalescent paired serum samples; high-titre dengue-specific IgM/IgG antibody in acute serum samples; or isolation of dengue virus. 10 The case definition for dengue hemorrhagic fever was proven dengue according to criteria of the WHO: signs of hemorrhagic tendency, thrombocytopenia (≤ 100 × 10 9 /L) and evidence of plasma leakage (≥ 20% increase in hematocrit, clinical fluid accumulation or hypoproteinemia). 
Assessment of covariables
We adjusted the statistical model for comorbidities associated with stroke, including atrial fibrillation or flutter, cancer, chronic obstructive pulmonary disease (COPD), chronic renal failure, diabetes mellitus, dyslipidemia, heart failure, hypertension and ischemic heart disease. 15, 16 As a measure of the severity of stroke and underlying diseases, we assessed the total admission days for each participant. 17, 18 Appendix 1 (available at www.cmaj.ca/ lookup/suppl/doi:10.1503/cmaj.170994/-/DC1) lists the detailed ICD-9-CM codes for covariables in this study. We also used hospitalization records to identify comorbidities, using validated algorithms. 19 
Statistical analysis
We tested the differences in baseline characteristics between the 2 cohorts by χ 2 and 2-sample Student t tests. We used a multivariable Cox proportional hazard model, with adjustment for sex, age, covariables and the competing risk of death, to calculate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for stroke. We performed stratified subgroup analyses with both single-variable and multivariable Cox proportional hazard models. We also conducted sensitivity analyses with alternative controls matched by propensity score. We used the Kaplan-Meier method to compare the cumulative incidences of stroke between the 2 cohorts with the log-rank test. We verified the assumption of proportional hazards with the graphical plotting method. We tested the seasonality of stroke in this study with the χ 2 goodness-of-fit test. We performed all statistical analyses with SAS statistical software, version 9.4 (SAS Institute), with significance set at α = 0.05.
Ethics approval
The study was approved by the Institutional Review Board of the China Medical University Hospital (CMUH104-REC2-115-CR2), which waived the requirement for informed consent because data in the NHIRD are de-identified.
Results
After matching, 13 787 patients were included in each of the dengue and control cohorts (Figure 1 ). The 2 cohorts had nearly equal proportions of females and males (Table 1) , although the slightly greater proportion of males in the control cohort was statistically significant. No other baseline characteristics were significantly different. Most patients were between 31 and 60 years of age. The mean follow-up period was 7.58 and 7.89 years in the dengue and control groups, respectively. The top 5 reasons for admission for the control group were digestive disorders (e.g., peptic ulcer, diarrhea, hemorrhoids), cardiopulmonary disorders (e.g., hypertension, arrhythmia, ischemic heart), metabolic disorders (e.g., diabetes, dyslipidemia), trauma and genitourinary disorders (e.g., urolithiasis, chronic renal failure).
The overall incidence rate of stroke was higher in the dengue cohort than in the control cohort (5.33 v. 3.72 per 1000 personyears), with adjusted HR of 1.16 (95% CI 1.01-1.32) ( Table 2) . Females in the dengue cohort and patients without comorbidities in the dengue cohort had higher risk ratios for stroke than those in the control cohort (for females, adjusted HR 1.32, 95% CI 
Time trends for risk of stroke
The incidence rate of stroke in the dengue cohort showed a timedependent trend during the follow-up period ( www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.170994/-/DC1) and was statistically significant (p < 0.001). The result of seasonality testing showed no significant seasonal effect (p = 0.5).
Risk factors for stroke
Appendix 2, Part 2 shows that patients with dengue hemorrhagic fever had the highest incidence rate of stroke (7.92 per 1000 personyears), with an adjusted HR of 1.40 (95% CI 1.10-1.77), followed by patients with repeat dengue infection (6.85 per 1000 person-years; adjusted HR 1.19, 95% CI 0.80-1.77) and patients with dengue fever (4.96 per 1000 person-years; adjusted HR 1.14, 95% CI 1.00-1.31).
In the multivariable analysis of risk factors for stroke (Appendix 2, Part 3), dengue was an independent risk factor for stroke (adjusted HR 1.18, 95% CI 1.03-1.34). Diabetes was the highest risk factor for stroke (adjusted HR 2.01, 95% CI 1.66-2. 
Interpretation
This study showed that patients with dengue had an increased risk of stroke, and this risk was time-dependent, as high as 2.49 times relative to control patients in the first 2 months. Patients with dengue who were male, who were older than 60 years or who had comorbidities had a higher incidence of stroke. The increased risk ratio for stroke in patients with dengue was greater for females and for those without comorbidity. It may be that male sex and comorbidities (including diabetes, dyslipidemia and hypertension) are stronger risk factors for stroke than dengue, and thus may mask the effects of dengue.
We found that patients with dengue had a higher risk of both hemorrhagic and ischemic stroke. Compared with previous studies reporting more hemorrhagic strokes than ischemic strokes among patients with dengue, [5] [6] [7] [8] [9] we observed more ischemic strokes. This difference may be related to universal screening for and surveillance of dengue, and to high medical accessibility in Taiwan, which could improve the early detection of ischemic stroke among patients with dengue. It is uncertain whether reported denguerelated hemorrhagic strokes were due to direct hemorrhage or to hemorrhagic conversion from ischemic stroke. Carod-Artal and associates 4 also assumed that dengue-related ischemic strokes might be underestimated. In our study, patients with dengue hemorrhagic fever had a higher risk of stroke than patients with dengue fever, which indicates that the pathogenesis of dengue hemorrhagic fever may play a role in the occurrence of stroke.
The mechanisms of dengue-related stroke are under investigation. Multiple pathways have been proposed, with the major focus on endothelial dysfunction leading to plasma leakage. 20, 21 Dengue virus could infect immune cells, inducing complex cascades of inflammatory mediators, such as cytokines, chemokines and complement. The interaction of these mediators with endothelial cells increases endothelial permeability and reduces the integrity of the endothelial barrier. 20 Moreover, cross-reaction of anti-NS1 antibodies and direct viral infection of endothelial cells and platelets contribute to hemorrhage, thrombocytopenia and plasma leakage. 22, 23 These immune-mediated mechanisms of dengue hemorrhagic fever in peripheral blood have also been found in the brain, where they cause breakdown of the bloodbrain barrier, leukocyte infiltration and local inflammation, followed by vasoconstriction, thromboembolism, cerebral edema, ischemia and hemorrhage. 4, 21, 24 A few case reports have shown atrial fibrillation as a complication of severe dengue, which may predispose these patients to stroke. 25, 26 The time trends for dengue-related stroke in this study suggest that the effects of dengue on stroke may be acute rather than chronic. Previous studies found that the inflammatory mediators and antigen-antibody complex caused by dengue were transient. 20, 21 Furthermore, reported cases of dengue-related stroke have ranged from 2 to 22 days after onset of fever.
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Limitations
This study had some limitations. In Taiwan, cases of dengue are clustered seasonally. 27 However, we found no significant seasonality leading to bias for the stroke cases in our study. This finding corresponds to that of a prior study indicating that there is no seasonality to ischemic stroke in Taiwan. 28 To ensure sufficient sample size and case ascertainment for patients with dengue, we used hospital records for the whole population of Taiwan; however, these records lack details about disease severity and medications. Therefore, we adjusted the data for total admission days, a measure that is highly correlated with disease severity. 17, 18 Total admission days and the proportion of patients admitted to the intensive care unit were comparable between the 2 study groups. To address potential confounding related to medications, we performed a subgroup analysis of patients without comorbidities, who would be less likely to receive medications such as antithrombotic or antihypertensive agents for stroke prevention; the results were consistent with the main analysis, with a stronger effect. Thus, disease severity and medications are unlikely to have biased our conclusions. Information about smoking, diet, body mass index, daily activity and ethnicity is not recorded in the NHIRD, so we could not adjust for these confounding variables. We used COPD as a surrogate in covariable adjustment. The NHIRD does not record laboratory data, so we were unable to perform further analysis on the effects of different dengue serotypes or the patients' bleeding profiles or inflammatory markers. Given the inherent limitations of administrative data, systematic bias, such as coding errors, was inevitable.
Conclusion
In this population-based study, the presence of dengue was associated with an increased risk of stroke. The effect of dengue on stroke may be acute rather than chronic. Clinicians in dengueendemic areas should be aware of this association, especially for patients with dengue who have neurologic deficits or for patients with stroke who have unexplained fever. Our findings may help with clinical risk evaluation and may serve as a basis for further investigation of the pathogenesis of dengue-related stroke.
